6 articles featuring Humulene
Living with chronic Lyme often feels like your body is under a constant, silent siege. Beyond the initial infection, the 'Lyme Storm' of systemic inflammation and relentless brain fog can make simple, daily tasks feel like climbing a mountain. While traditional protocols focus heavily on hitting the bacteria, there is a missing piece in the puzzle: the Endocannabinoid System (ECS). By leveraging specific terpenes—Beta-Caryophyllene (BCP) and Alpha-Humulene—you may support your body’s internal regulatory network to regain balance without the psychoactive effects often associated with cannabis.
Lyme disease, triggered by the spirochete Borrelia burgdorferi, remains a complex clinical challenge. Even after standard antibiotic protocols, many patients transition into Post-Treatment Lyme Disease Syndrome (PTLDS). This state is defined by persistent cytokine activation, systemic inflammation, and a central nervous system (CNS) that may remain in a hyper-sensitive state.
Lyme disease is often viewed as a multi-systemic inflammatory burden. For those navigating the complexities of Post-Treatment Lyme Disease Syndrome (PTLDS), the cycle of joint pain and neurological dysfunction may persist after standard antibiotic courses conclude. Because conventional treatments sometimes fail to address the underlying cytokine surge, the wellness community is exploring terpene-specific formulations to support symptom management.
Chronic Lyme disease often involves a long-term state of physiological stress. For those dealing with Post-Treatment Lyme Disease Syndrome (PTLDS), the primary hurdle involves managing the dysregulated inflammation that persists after the initial infection. If you are looking to support your system, Beta-Caryophyllene (BCP) and Alpha-Humulene may offer assistance in regulating the nervous system.
Lyme disease represents a significant challenge for high-performance athletes. It affects training consistency, VO2 max, and the ability to maintain explosive power. Recovery windows may extend from hours into days, and even moderate intensity work can become difficult to sustain.
Living with the 'Lyme Storm' often means navigating a cycle of antibiotics and physical pain. When standard medical protocols leave you managing systemic inflammation and cognitive decline, looking toward secondary metabolites—specifically terpenes and minor cannabinoids—may offer a nuanced way to support your symptoms. By targeting specific biological pathways, these compounds may move beyond simply masking pain and help address the underlying neuro-inflammatory response.